home / stock / eypt / eypt news


EYPT News and Press, EyePoint Pharmaceuticals Inc. From 05/06/24

Stock Information

Company Name: EyePoint Pharmaceuticals Inc.
Stock Symbol: EYPT
Market: NASDAQ
Website: eyepointpharma.com

Menu

EYPT EYPT Quote EYPT Short EYPT News EYPT Articles EYPT Message Board
Get EYPT Alerts

News, Short Squeeze, Breakout and More Instantly...

EYPT - GME, ONVO and POAI among pre-market losers

2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...

EYPT - EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU(TM) in Non-Proliferative Diabetic Retinopathy

– DURAVYU demonstrates stable or improved disease severity with reduced rates of NPDR progression at nine months – – DURAVYU continues to demonstrate favorable safety and tolerability profile with no drug-related serious adverse events – &#x...

EYPT - Expected US Company Earnings on Wednesday, May 1st, 2024

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

EYPT - (EYPT) Technical Data

2024-05-01 02:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EYPT - How the (EYPT) price action is used to our Advantage

2024-04-21 08:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EYPT - Baird sees weakness in Ocular shares "overdone" in wake of Phase 1 data

2024-04-19 18:07:40 ET More on Ocular Therapeutix Ocular Therapeutix's Impressive Surge: A Strategic Insight Ocular Therapeutix: Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement Ocular marks early-stage trial win for diabetic retinopathy candidate Oc...

EYPT - Veru, EyePoint Pharmaceuticals, SINTX Technologies among healthcare movers

2024-04-18 10:00:26 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...

EYPT - (EYPT) Long Term Investment Analysis

2024-04-11 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

EYPT - EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board – - Usha Chakravarthy, M.B.B.S, PhD., Allen Ho, M.D. FACS FASRS and Frank Holz, M.D., F.E.B.O, F.A.R.V.O join in advance of global Phase 3 clinical trials for EYP-1901(DURAVYU) i...

EYPT - (EYPT) Investment Report

2024-03-12 08:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10